Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ADIL
#4023
Adial Pharmaceuticals, Inc
2.5
3
+3.27%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+3.27%
Aylık değişim
+1000.00%
6 aylık değişim
+548.72%
Yıllık değişim
+232.89%
Önceki kapanış
2.4
5
Open
2.5
3
Bid
Ask
Low
2.5
3
High
2.5
3
Hacim
1
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
ADIL
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
27.63 K
37.95 K
45.63 K
162.19 K
262.98 K
—
Valuation ratios
Enterprise value
—
—
—
-2.54 M
-3.48 M
-15.57 M
Price to earnings ratio
—
—
—
-0.02
-0.01
-0.16
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
-0.01
-0.03
-0.07
Price to book ratio
—
—
—
0.02
0.05
0.07
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
1.98
-2.6
-2.22
-1.08
-2.62
-1.66
Return on equity %
2.73
-5.54
-3.89
-1.25
-3.24
-2.31
Return on invested capital %
12.16 K
-10.75 K
-4 697.79
-1 964.47
-2 507.23
—
Gross margin %
100
100
—
—
—
—
Operating margin %
2 906.38
-41.49 K
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
2 897.07
-41.78 K
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
4.2
3.69
—
Current ratio
3.41
2.37
2.67
4.9
4.16
15.51
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.06
0.01
0
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
0
0.01
—
—
—
Long term debt to total equity ratio
—
0.01
0.01
—
—
—
Per share metrics
Operating cash flow per share
—
—
-279.23
-119.45
-35.67
-19.74
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
99.89
49.61
19.33
47.49
Net current asset value per share
—
—
119.32
56.13
20.92
50.93
Tangible book value per share
—
—
75.46
71.59
20.95
47.29
Working capital per share
—
—
74.61
44.67
15.89
36.68
Book value per share
—
—
81.79
71.66
20.96
47.33
Haberler
Adial Pharmaceuticals hisseleri FDA politika değişikliğiyle yükseldi
Adial Pharmaceuticals stock rises on FDA policy shift
Adial Pharmaceuticals, AD04 için tek pivotal deneme yolunu değerlendiriyor
Adial Pharmaceuticals eyes single pivotal trial path for AD04
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories! - TipRanks.com
Adial Pharmaceuticals hisseleri 1’e 25 ters bölünme duyurusu sonrası düşüşte
Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split
Adial Pharmaceuticals 1’e 25 ters hisse bölünmesi duyurdu
Adial Pharmaceuticals announces 1-for-25 reverse stock split
Adial Pharmaceuticals yönetim kurulu üyesi James W. Newman, Jr.’ın istifasını duyurdu
Adial Pharmaceuticals announces resignation of board member James W. Newman, Jr.
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?